Medplus Health Services share news, announcements and annual reports
NSE: MEDPLUSBSE: 543427RetailingSmall Cap
Medplus Health Services Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2021 · Issue price ₹796
Last close ₹579.90down ₹18.15 (3.03%)BSE ₹579.80
Share price at the NSE close on 30 Oct 2026. Previous close ₹598.05.
30 Oct: open ₹590.00, high ₹595.00, low ₹565.60
52-week range of traded prices to 30 Oct 2026
₹565.60Low, 30 Oct 2026₹1,022.20High, 21 May 2026
- The board meets on 6 Nov 2026 to consider: buyback. The notice · Every company's board meetings
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,967 Cr555th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 33.01
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.37
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,07,35367.0% delivered
Medplus Health Services share news and announcements
679 announcements, routine notices left out, newest first. Page 12 of 14.
Nov 2023
10 Nov · Meeting
8 Nov · Related Party Transactions
8 Nov · Results
4 Nov · Business
Oct 2023
31 Oct · Meeting
25 Oct · Board meeting
Meeting on 8 Nov 2023: “MEDPLUS HEALTH SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 08-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Y”11 Oct · Board meeting
5 Oct · Board meeting
Sep 2023
21 Sep · Board meeting
Aug 2023
10 Aug · Business
10 Aug · Analysts
7 Aug · Results
Jul 2023
11 Jul · Board meeting
Meeting on 7 Aug 2023: “MEDPLUS HEALTH SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarte”
Jun 2023
20 Jun · Meeting
16 Jun · Analysts
May 2023
25 May · Related Party Transactions
25 May · Results
25 May · Board meeting
15 May · Business